Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Avoiding mistakes in anti-VEGF intravitreal injection therapy].
Framme C, Junker B, Feltgen N, Hoerauf H, Striebe NA, Wachtlin J, Volkmann I. Framme C, et al. Among authors: wachtlin j. Ophthalmologe. 2022 Mar;119(3):309-326. doi: 10.1007/s00347-021-01553-8. Epub 2022 Jan 14. Ophthalmologe. 2022. PMID: 35029746 German.
[Reliability and safety of intravitreal Ozurdex injections. The ZERO study].
Schmitz K, Maier M, Clemens CR, Höhn F, Wachtlin J, Lehmann F, Bertelmann T, Rüdiger K, Horn M, Bezatis A, Spital G, Meyer CH; German Retinal Vein Occlusion Group. Schmitz K, et al. Among authors: wachtlin j. Ophthalmologe. 2014 Jan;111(1):44-52. doi: 10.1007/s00347-012-2737-2. Ophthalmologe. 2014. PMID: 23559321 German.
Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Eter N, Mohr A, Wachtlin J, Feltgen N, Shirlaw A, Leaback R; German Ozurdex in RVO Real World Study Group. Eter N, et al. Among authors: wachtlin j. Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):77-87. doi: 10.1007/s00417-016-3431-x. Epub 2016 Jul 26. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27460280 Free PMC article. Clinical Trial.
Erratum to: Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Eter N, Mohr A, Wachtlin J, Feltgen N, Shirlaw A, Leaback R; German Ozurdex in RVO Real World Study Group. Eter N, et al. Among authors: wachtlin j. Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):89. doi: 10.1007/s00417-016-3568-7. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27957602 Free PMC article. No abstract available.
Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study.
Paul C, Heun C, Müller HH, Hoerauf H, Feltgen N, Wachtlin J, Kaymak H, Mennel S, Koss MJ, Fauser S, Maier MM, Schumann RG, Mueller S, Chang P, Schmitz-Valckenberg S, Kazerounian S, Szurman P, Lommatzsch A, Bertelmann T. Paul C, et al. Among authors: wachtlin j. Br J Ophthalmol. 2018 Aug;102(8):1092-1097. doi: 10.1136/bjophthalmol-2017-310874. Epub 2017 Oct 31. Br J Ophthalmol. 2018. PMID: 29089354
Aflibercept for Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in Germany: Twelve-Month Outcomes of PERSEUS.
Framme C, Eter N, Hamacher T, Hasanbasic Z, Jochmann C, Johnson KT, Kahl M, Sachs H, Schilling H, Thelen U, Wiedemann P, Wachtlin J; Prospective Noninterventional Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients with Neovascular Age-Related Macular Degeneration Study Group. Framme C, et al. Among authors: wachtlin j. Ophthalmol Retina. 2018 Jun;2(6):539-549. doi: 10.1016/j.oret.2017.09.017. Epub 2017 Nov 20. Ophthalmol Retina. 2018. PMID: 31047606
[Surgery of large and persistent macular holes].
Haritoglou C, Wolf A, Wachtlin J. Haritoglou C, et al. Among authors: wachtlin j. Ophthalmologe. 2019 Nov;116(11):1011-1019. doi: 10.1007/s00347-019-00949-x. Ophthalmologe. 2019. PMID: 31428845 Review. German.
72 results